Who
Michael M. Abecassis
Director
Company insider
Files Form 4 as: Director, PharmaCyte Biotech.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 20 Nov 2023
- Last trade
- 31 Mar 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Mar 2026filed 17 Jul 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code J | —0 | filing |
| 31 Mar 2026filed 17 Jul 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code J | —0 | filing |
| 31 Mar 2026filed 2 Apr 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —119,170 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —119,170 at $0.00 | filing |
| 12 Dec 2025filed 12 Dec 2025 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 12 Dec 2025filed 12 Dec 2025 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Code F | $17K16,875 at $1.02 | filing |
| 25 Apr 2025filed 12 Dec 2025 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,233 at $0.00 | filing |
| 30 Apr 2024filed 17 Jul 2024 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,009 at $0.00 | filing |
| 20 Nov 2023filed 22 Nov 2023 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —61,248 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.